Tecentriq (atezolizumab) - Roche
Tecentriq: Regulatory approval in combination with nab-paclitaxel in EU and Japan for 1L TNBC in 2019 (Roche) - Jul 26, 2019 - H1 2019 Results: Regulatory approval in combination with nab-paclitaxel in US and EU for 1L non sq NSCLC in 2019 
European regulatory • Japanese regulatory • sBLA
https://www.roche.com/dam/jcr:bf0aee4a-439c-4656-a3b9-d61e5752dde2/en/irp190725.pdf
 
Jul 26, 2019
 
 
a8d40d31-70d6-4c3a-a2f6-5242c5e4613b.jpg